Bowhead Specialty (NYSE:BOW) Price Target Raised to $33.00 at JPMorgan Chase & Co.

Bowhead Specialty (NYSE:BOW) had its price target upped by JPMorgan Chase & Co. from $30.00 to $33.00 in a research note issued to investors on Monday,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.

A number of other equities research analysts have also recently weighed in on BOW. Morgan Stanley lifted their price target on shares of Bowhead Specialty from $28.00 to $30.00 and gave the company an “equal weight” rating in a research report on Monday, July 6th. Citizens Jmp decreased their price objective on shares of Bowhead Specialty from $38.00 to $35.00 and set a “market outperform” rating on the stock in a report on Monday, April 13th. Weiss Ratings raised shares of Bowhead Specialty from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 23rd. Keefe, Bruyette & Woods lifted their target price on shares of Bowhead Specialty from $34.00 to $36.00 and gave the company an “outperform” rating in a report on Wednesday, July 8th. Finally, Piper Sandler lifted their target price on shares of Bowhead Specialty from $32.00 to $36.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. Five equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $33.71.

Bowhead Specialty Stock Performance

Shares of Bowhead Specialty stock opened at $30.48 on Monday. Bowhead Specialty has a 52 week low of $21.21 and a 52 week high of $33.88. The business’s fifty day simple moving average is $28.54 and its 200-day simple moving average is $25.81. The firm has a market cap of $1.00 billion, a PE ratio of 17.62, a price-to-earnings-growth ratio of 0.92 and a beta of -0.10. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 0.32.

Bowhead Specialty (NYSE:BOW) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.48 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.42 by $0.06. The firm had revenue of $155.69 million during the quarter, compared to the consensus estimate of $211.74 million. Bowhead Specialty had a return on equity of 13.80% and a net margin of 9.99%. Equities analysts forecast that Bowhead Specialty will post 1.97 earnings per share for the current year.

Institutional Trading of Bowhead Specialty

Several hedge funds have recently made changes to their positions in the business. Langdon Equity Partners acquired a new position in shares of Bowhead Specialty in the fourth quarter valued at approximately $28,000. Versant Capital Management Inc increased its stake in Bowhead Specialty by 262.6% during the 2nd quarter. Versant Capital Management Inc now owns 1,037 shares of the company’s stock worth $31,000 after buying an additional 751 shares during the period. Parallel Advisors LLC lifted its holdings in Bowhead Specialty by 181.4% during the 1st quarter. Parallel Advisors LLC now owns 1,652 shares of the company’s stock worth $37,000 after buying an additional 1,065 shares in the last quarter. CWM LLC lifted its holdings in Bowhead Specialty by 257.7% during the 4th quarter. CWM LLC now owns 1,481 shares of the company’s stock worth $42,000 after buying an additional 1,067 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new position in Bowhead Specialty in the 2nd quarter valued at approximately $52,000.

About Bowhead Specialty

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.